(British Medical Journal, published 13 August 2025)
This paper with over 148,000 individuals concluded that drug treatment for ADHD was associated with beneficial effects in reducing the risks of suicidal behaviours, substance misuse, transport accidents, and criminality but not accidental injuries when considering first event rate. The risk reductions were more pronounced for recurrent events, with reduced rates for all five outcomes. This target trial emulation study using national register data provides evidence that is representative of patients in routine clinical settings.
For full access, please click here: https://www.bmj.com/content/390/bmj-2024-083658